Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
241-253
Author(s):
G. Ranieri and G. Gasparini
Advances in the Chemistry and Pharmacology of Ecteinascidins, A Promising New Class of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
257-276
Author(s):
I. Manzanares, C. Cuevas, R. Garcia-Nieto, E. Marco and F. Gago
Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
313-329
Author(s):
Mira Susa, Markus Glatt and Anna Teti
Mechanism-Based Inactivators as Probes of Cytochrome P450 Structure and Function
Journal:
Current Drug Metabolism
Volume:
2
Page:
215-243
Author(s):
Ute M. Kent, Monica I. Jushchhyshyn and Paul F. Hollenberg
Role of Thymidine Phosphorylase in Biomodulation of Fluoropyrimidines
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
257-267
Author(s):
T. Morita, A. Matsuzaki, K. Suzuki and A. Tokue
Modifications in the upper or Velbenamine Part of the Vinca Alkaloids have Major Implications for Tubulin Interacting Activities
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1181-1197
Author(s):
Jacques Fahy
General and Recent Aspects of the Chemistry and Structure Activity Relationships of Taxoids
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1229-1249
Author(s):
Francoise Gueritte
Preclinical Evaluation of New Taxoids
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1251-1257
Author(s):
M. -C. Bissery
Spongistatins as Tubulin Targeting Agents
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1291-1296
Author(s):
F. M. Uckun, C. Mao, S. -T. jan, H. Huang, A. O. Vassilev, C. S. Navara and R. K. Narla
Epilogue
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1297-1301
Author(s):
Jacques Fahy and Bridget T. Hill